Fresenius Medical Care AG was originally established as a joint stock company on August 5, 1996 and registered as a joint stock company on February 10, 2006. The company is the world's leading provider of products and services for patients with kidney disease. As a vertically integrated medical technology (MedTech) and medical services company, Fresenius Medical Care combines medical device engineering and manufacturing expertise with comprehensive patient care. In three operating segments, care delivery (CD), value-based care (VBC) and care support (CE), the company provides a full range of medical services, systems, devices, technologies, products and pharmaceuticals to provide high-quality care for kidney disease patients worldwide.